Ohori M - Search Results

1

Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.

Graefen M, Ohori M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Erbersdobler A, Henke RP, Huland H, Wheeler TM, Slawin K, Scardino PT, Kattan MW. Graefen M, et al. Among authors: ohori m. J Urol. 2004 Jan;171(1):200-3. doi: 10.1097/01.ju.0000099161.70713.c8. J Urol. 2004. PMID: 14665876

2

Prostate biopsy techniques and indications: when, where, and how?

Scherr DS, Eastham J, Ohori M, Scardino PT. Scherr DS, et al. Among authors: ohori m. Semin Urol Oncol. 2002 Feb;20(1):18-31. doi: 10.1053/suro.2002.30395. Semin Urol Oncol. 2002. PMID: 11828354 Review.

3

[The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].

Koh H, Maru N, Muramoto M, Wheeler TM, Scardino PT, Ohori M. Koh H, et al. Among authors: ohori m. Nihon Hinyokika Gakkai Zasshi. 2002 Jul;93(5):595-601. doi: 10.5980/jpnjurol1989.93.595. Nihon Hinyokika Gakkai Zasshi. 2002. PMID: 12174634 Free article. Japanese.

4

Localized prostate cancer.

Ohori M, Scardino PT. Ohori M, et al. Curr Probl Surg. 2002 Sep;39(9):833-957. doi: 10.1067/msg.2002.126335. Curr Probl Surg. 2002. PMID: 12376729 Review. No abstract available.

5

Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.

Yossepowitch O, Sircar K, Scardino PT, Ohori M, Kattan MW, Wheeler TM, Reuter VE. Yossepowitch O, et al. Among authors: ohori m. J Urol. 2002 Nov;168(5):2011-5. doi: 10.1016/S0022-5347(05)64284-X. J Urol. 2002. PMID: 12394697

6

Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?

Ohori M, Kattan MW, Utsunomiya T, Suyama K, Scardino PT, Wheeler TM. Ohori M, et al. J Urol. 2003 Mar;169(3):964-8. doi: 10.1097/01.ju.0000049963.28489.ab. J Urol. 2003. PMID: 12576823

7

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.

Kattan MW, Shariat SF, Andrews B, Zhu K, Canto E, Matsumoto K, Muramoto M, Scardino PT, Ohori M, Wheeler TM, Slawin KM. Kattan MW, et al. Among authors: ohori m. J Clin Oncol. 2003 Oct 1;21(19):3573-9. doi: 10.1200/JCO.2003.12.037. Epub 2003 Aug 11. J Clin Oncol. 2003. PMID: 12913106 Clinical Trial.

8

A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session.

Lopez-Corona E, Ohori M, Scardino PT, Reuter VE, Gonen M, Kattan MW. Lopez-Corona E, et al. Among authors: ohori m. J Urol. 2003 Oct;170(4 Pt 1):1184-8; discussion 1188. doi: 10.1097/01.ju.0000087451.64657.fa. J Urol. 2003. PMID: 14501721

9

A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.

Koh H, Kattan MW, Scardino PT, Suyama K, Maru N, Slawin K, Wheeler TM, Ohori M. Koh H, et al. Among authors: ohori m. J Urol. 2003 Oct;170(4 Pt 1):1203-8. doi: 10.1097/01.ju.0000085074.62960.7b. J Urol. 2003. PMID: 14501725

10

Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.

Kattan MW, Eastham JA, Wheeler TM, Maru N, Scardino PT, Erbersdobler A, Graefen M, Huland H, Koh H, Shariat S, Slawin KM, Ohori M. Kattan MW, et al. Among authors: ohori m. J Urol. 2003 Nov;170(5):1792-7. doi: 10.1097/01.ju.0000091806.70171.41. J Urol. 2003. PMID: 14532778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page